Trevor James
The Hepatitis B vaccine is recommended for all infants at birth and for children up to 18 years. The World Health Organization (WHO) recommends a 0, 1, and 6-month vaccination schedule, with the first dose ideally administered within 24 hours of birth. This vaccine is crucial as it protects against hepatitis B, a liver infection that can cause severe liver disease and increase the risk of liver cancer. Completing the vaccine series is essential for maximum protection, and it is available at doctors' offices, local health departments, or clinics. While side effects are typically mild, parents should be aware of the rare possibility of a severe allergic reaction.
| Characteristics | Values |
|---|---|
| Who should get the Hep B vaccine? | The Hep B vaccine is recommended for all newborns, children up to 18 years of age, and adults at higher risk for infection or those who want protection from the virus. |
| When should children get the Hep B vaccine? | The first dose is recommended within 24 hours of birth, or within 12 hours if the mother carries the virus. The second dose is given one month later, and the third dose is given at six months. |
| Are there alternative schedules for the vaccine? | Yes, there are alternative schedules for the Hep B vaccine. A 4-dose series is also available, with doses at 0, 7, and 21-30 days, followed by a booster at 12 months. |
| Are there any side effects? | Side effects are usually mild and can include low fever, headache, tiredness, loss of appetite, and soreness or redness at the injection site. There is a small risk of fainting and a very rare chance of a severe allergic reaction. |
| Can the Hep B vaccine be combined with other vaccines? | Yes, the Hep B vaccine can be given as a stand-alone vaccine or in combination with other vaccines such as DTaP, IPV, Hib, or HepA. |
Explore related products
What You'll Learn
Hepatitis B vaccine schedule for children
The Hepatitis B vaccine is generally administered as a three-dose series, with the first dose typically given within 24 hours of birth. However, if a newborn's mother carries the hepatitis B virus, the baby must receive the vaccine within 12 hours of birth, along with a hepatitis B immune globulin (HBIG) shot for immediate protection. For infants weighing less than 2,000 grams at birth, the first dose is typically administered at one month of age or when they are discharged from the hospital, whichever comes first.
The second dose of the hepatitis B vaccine is usually given one month after the first dose, and the third dose is administered at six months of age. This three-dose schedule, given at 0, 1, and 6 months, is recommended by the World Health Organization (WHO) and provides long-term protection against hepatitis B.
In certain cases, an alternative four-dose schedule may be considered. This involves administering three doses within the first month, followed by a booster dose at 12 months. This alternative schedule is often recommended for adolescents aged 18 years and older.
It is important to note that vaccine schedules may vary depending on country-specific guidelines and recommendations. Additionally, some combination vaccines, such as the pentavalent and hexavalent vaccines, offer protection against hepatitis B along with other diseases. These combination vaccines can be given as part of the recommended schedule to complete the hepatitis B vaccine series.
Chicken Pox Vaccine: What's the Abbreviation?
You may want to see also
Explore related products
Side effects and risks
The Hepatitis B vaccine contains a killed (inactivated) virus, so it cannot cause hepatitis. The World Health Organization (WHO) recommends that all infants receive the first dose of the hepatitis B vaccine within 24 hours of birth. The additional two doses are given at one month and six months of age.
The Hepatitis B vaccine is considered safe for children and infants. Side effects are usually mild and can include a low fever, headache, tiredness, loss of appetite, and soreness or redness at the injection site. As with any vaccine, there is a small risk of fainting, and a very small chance of an allergic reaction.
If your child has ever had a serious allergic reaction, or any allergic reaction after an earlier dose of the vaccine or to baker's yeast, talk to your doctor about whether the vaccine is a good idea.
In the early 1990s, the CDC conducted a study of healthy full-term newborns to determine whether hepatitis B vaccination increased the risk of fever and/or suspected sepsis. The study found no evidence of increased fevers, sepsis evaluations, allergy or brain problems or medical procedures after newborn hepatitis B vaccination. This was the largest case series review of hepatitis B vaccination reports among newborn babies and infants. Several studies have evaluated a possible link between hepatitis B vaccination and multiple sclerosis or optic neuritis, but no link has been found.
The Vaccine Adverse Event Reporting System (VAERS) is an early warning system co-managed by the CDC and FDA that monitors for potential vaccine safety problems. Healthcare providers and vaccine manufacturers are required by law to report certain adverse events following vaccination to VAERS; patients and caregivers can also submit reports. A review of VAERS reports of adverse events following hepatitis B vaccination from 2005 through 2015 found no differences between vaccinated and unvaccinated newborns.
Hepatitis B infection may result in a wide variety of acute or chronic manifestations, including anorexia, low-grade fever, and, in more severe cases, tender enlargement of the liver associated with jaundice. Ninety percent of newborn infants infected with the hepatitis B virus become chronic carriers, and up to 15 percent of those who recover from acute hepatitis become chronic carriers. Therefore, the hepatitis B vaccine is essential to protecting infants and children from infection and lowering their lifetime risk of liver cancer.
Where Are Vaccines Manufactured?
You may want to see also
Explore related products
Who should not get the vaccine
The Hepatitis B vaccine is generally recommended for all infants at birth, children up to age 18, adults at high risk, and adults 19-59. However, there are certain cases where individuals should not receive the vaccine or should consult a doctor before proceeding.
Firstly, doctors delay giving the vaccine to babies who weigh less than 4 pounds, 7 ounces (2,000 grams) at birth whose mothers do not have the virus in their blood. In such cases, the baby will get the first dose at 1 month of age or when discharged from the hospital.
Secondly, individuals with a history of serious allergic reactions, particularly to baker's yeast or a previous dose of the vaccine, should consult a doctor before proceeding. This includes those with documented yeast allergies, as the vaccine may not be recommended for them.
Additionally, those who have previously received the vaccine as infants, children, adolescents, or adults and have a normal immune status typically do not require revaccination.
It is important to note that the Hepatitis B vaccine is safe for pregnant women, but one brand, PreHevbrio, is not recommended during pregnancy due to a lack of safety data. As with any medical decision, it is always best to consult a healthcare professional for personalized advice and to determine if the Hepatitis B vaccine is suitable for you or your child.
Vaccines for Employees: Which BBP Has Them?
You may want to see also
Explore related products
Coadministration with other vaccines
The Hepatitis B vaccine is generally administered in three doses, with shots given at 0, 1, and 6 months. The World Health Organization (WHO) recommends that all newborns receive the first dose of the vaccine within 24 hours of birth, with additional shots at 1 and 6 months of age. This birth dose is crucial for protection against hepatitis B throughout life.
The Hepatitis B vaccine is sometimes given in combination with other vaccines, such as DTaP, IPV, Hib, or HepA. This is known as a pentavalent or hexavalent vaccine, protecting against five or six diseases, respectively.
When it comes to coadministration with other vaccines, there have been discussions and concerns about the concurrent administration of the COVID-19 vaccine and the Hepatitis B vaccine. Some health authorities recommend an interval of at least 14 days between COVID-19 vaccination and other vaccines, while others, like the CDC, do not support any time restrictions, even allowing for administration on the same day.
The limited data available suggests that co-administration of these two vaccines does not pose additional risks to individuals. However, these findings are based on a small cohort, and more data is needed to determine the efficacy of the vaccines when given within a short period. As a result, healthcare facilities worldwide need to share experiences and reach a consensus on this issue.
In terms of other vaccines, the Hepatitis B vaccine is often given in combination with other routine immunizations for children and adolescents. For example, the HepA-HepB (Twinrix) vaccine is a 3-dose series (0, 1, and 6 months) or a 4-dose series (0, 7, and 21-30 days, followed by a booster at 12 months). This vaccine is recommended for unvaccinated persons up to 18 years of age and adolescents over 18.
Additionally, in many countries, it is standard to provide a pentavalent vaccine, which includes protection against hepatitis B and four other diseases. This vaccine is typically given at 6 weeks of age to protect infants from birth.
In summary, the Hepatitis B vaccine is often coadministered with other vaccines, either in combination or with concurrent or adjacent dosing schedules. While there have been specific concerns about coadministration with the COVID-19 vaccine, current evidence suggests no additional risks, although more data is needed to determine efficacy when given simultaneously.
Hepatitis B Vaccine: Effective Defense Against Hepatitis C?
You may want to see also
Explore related products
Long-term protection and revaccination
The Hepatitis B vaccine is recommended for all infants, and the World Health Organization (WHO) advises that the first dose be administered within 24 hours of birth. The remaining two doses are then given at one month and six months of age. This vaccine series, when started at birth, provides lifetime protection against hepatitis B, hepatitis delta, and liver cancer.
For infants weighing less than 2000 grams, the first dose is delayed until one month of age or when the baby is discharged from the hospital. In total, these infants receive four doses, with the final dose administered at six months.
The Hepatitis B vaccine is also crucial for infants born to mothers with hepatitis B. These infants must receive the vaccine within 12 hours of birth, along with a hepatitis B immune globulin (HBIG) injection to provide immediate protection.
While the Hepatitis B vaccine is typically given as a three-dose series, alternative schedules are available. For instance, Engerix-B is a three-dose vaccine that can be accelerated to four doses, with three shots given within two months and a booster at one year for maximum long-term protection. Twinrix is another option, offering protection against hepatitis A and B. This vaccine is administered as three doses within one month, followed by a booster at one year.
The Hepatitis B vaccine is not only important for infants but also for older children and adults. The vaccine is recommended for children over one year of age and adults, especially those at high risk of infection due to their jobs, lifestyle, living situations, or country of birth. Revaccination is generally not advised for individuals with normal immune status who were vaccinated as infants, children, or adults. However, certain populations, such as those with anti-HBs<10mlU/mL, may require revaccination.
The Hepatitis B vaccine offers long-term protection against a preventable chronic liver disease. It is essential to consult a healthcare provider to determine the recommended vaccine schedule for each age group and individual circumstances.
Chickenpox Vaccine: When Did It Start?
You may want to see also
Frequently asked questions
The World Health Organization (WHO) recommends the Hep B vaccine for all newborns, children up to 18 years of age, and adults at higher risk of infection. In the US, the CDC recommends the vaccine for all newborns, children up to 18, adults aged 19-59, and adults 60+ at high risk.
The Hep B vaccine is typically given in three doses, with shots administered at 0, 1, and 6 months. The first dose is usually given within 24 hours of birth, or within 12 hours if the mother is a hepatitis B carrier. The second dose is given one month later, and the third dose is given at least four months after the second dose.
Side effects are usually mild and can include a low fever, headache, tiredness, loss of appetite, and soreness or redness at the injection site. There is a small risk of fainting, and a very rare chance of a severe allergic reaction (about 1 in 600,000 doses).
Yes, the Hep B vaccine can be administered concurrently with other vaccines, such as DTaP, IPV, Hib, or HepA. Combination vaccines, such as the pentavalent and hexavalent vaccines, can provide protection against up to six diseases, including hepatitis B.
